ABVC
ABVC Biopharma IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$26.52M
P/E Ratio
—
EPS
$-0.34
Beta
0.54
52W High
$3.40
52W Low
$0.88
50-Day MA
$1.35
200-Day MA
$1.80
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About ABVC Biopharma Inc
American BriVision (Holding) Corporation, a clinical-stage biopharmaceutical company, develops drugs and medical devices to meet unmet medical needs in the United States.
Fundamentals
| Revenue (TTM) | 797,920 |
| Gross Profit (TTM) | 797,920 |
| EBITDA | $-8.01M |
| Operating Margin | 0.00% |
| Return on Equity | -87.80% |
| Return on Assets | -29.00% |
| Revenue/Share (TTM) | $0.05 |
| Book Value | $0.43 |
| Price-to-Book | 2.46 |
| Price-to-Sales (TTM) | 27.42 |
| EV/Revenue | 40.1 |
| EV/EBITDA | -1.90 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 104.50% |
| Shares Outstanding | $26.00M |
| Float | $20.44M |
| % Insiders | 18.57% |
| % Institutions | 3.14% |
Historical Volatility
HV 10-Day
79.88%
HV 20-Day
147.76%
HV 30-Day
128.61%
HV 60-Day
105.88%
HV Rank
89.3%
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ABVC and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 7/29/2026